Your browser doesn't support javascript.
loading
Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.
Cooney, Erin E; Reisner, Sari L; Saleem, Haneefa T; Althoff, Keri N; Beckham, S Wilson; Radix, Asa; Cannon, Christopher M; Schneider, Jason S; Haw, J Sonya; Rodriguez, Allan E; Wawrzyniak, Andrew J; Poteat, Tonia C; Mayer, Kenneth H; Beyrer, Chris; Wirtz, Andrea L.
Afiliación
  • Cooney EE; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD. Electronic address: Ecooney2@jhmi.edu.
  • Reisner SL; Fenway Health, The Fenway Institute, Boston, MA; Brigham and Women's Hospital, Division of Endocrinology, Diabetes, and Hypertension, Boston, MA; Harvard Medical School, Department of Medicine, Boston, MA; Harvard TH Chan School of Public Health, Department of Epidemiology, Boston, MA.
  • Saleem HT; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD.
  • Althoff KN; Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD.
  • Beckham SW; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD; Johns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, Baltimore, MD.
  • Radix A; Callen-Lorde Community Health Center, New York, NY.
  • Cannon CM; Whitman-Walker Institute, Washington, DC.
  • Schneider JS; Emory University, School of Medicine, Atlanta, GA.
  • Haw JS; Emory University, School of Medicine, Atlanta, GA.
  • Rodriguez AE; University of Miami Miller School of Medicine, Division of Infectious Diseases, Department of Medicine, Miami, FL.
  • Wawrzyniak AJ; University of Miami Miller School of Medicine, Department of Psychiatry and Behavioral Sciences, Miami, FL.
  • Poteat TC; University of North Carolina School of Medicine, Center for Health Equity Research, Chapel Hill, NC.
  • Mayer KH; Fenway Health, The Fenway Institute, Boston, MA; Harvard Medical School, Department of Medicine, Boston, MA.
  • Beyrer C; Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD.
  • Wirtz AL; Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD.
Ann Epidemiol ; 70: 23-31, 2022 06.
Article en En | MEDLINE | ID: mdl-35398255
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Personas Transgénero / Profilaxis Pre-Exposición Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Ann Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Personas Transgénero / Profilaxis Pre-Exposición Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Ann Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos